Curcumin protects against hepatic ischemia/reperfusion induced injury through inhibiting TLR4/NF-&#x03BA;B pathway

Lu Wang; Ning Li; Dongdong Lin; Yunjin Zang

doi:10.18632/oncotarget.18676

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Learn about our FREE

Post-Publication Promotion Services

50% on all publication fees until the end of 2024.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

Curcumin protects against hepatic ischemia/reperfusion induced injury through inhibiting TLR4/NF-κB pathway

Lu Wang, Ning Li, Dongdong Lin and Yunjin Zang _

PDF | HTML | How to cite

Oncotarget. 2017; 8:65414-65420. https://doi.org/10.18632/oncotarget.18676

Metrics: PDF 2105 views | HTML 3430 views | ?

Abstract

Lu Wang1, Ning Li1, Dongdong Lin1 and Yunjin Zang1

1Department of Surgery and Liver Transplantation Center, Capital Medical University Affiliated Youan Hospital, Beijing, China

Correspondence to:

Yunjin Zang, email: [email protected]

Keywords: hepatic ischemia reperfusion injury, curcumin, TLR4, NF-κB, inflammatory cytokine

Received: February 25, 2017 Accepted: May 12, 2017 Published: June 27, 2017

ABSTRACT

The TLR4/NF-κB pathway had important roles in hepatic ischemia/reperfusion (I/R) injury. In this study, we reported a protective effect of curcumin against hepatic I/R injury via TLR4/NF-κB pathway. Curcumin significantly inhibited cell apoptosis, and decreased levels of LDH and production of TNF-a, IL-1b, and IL-6 in the cell supernatant. In addition, curcumin ameliorated elevated TLR4 and NF-κB caused by hypoxia/reoxygenation stimulation in BRL-3A cells. In vivo assays revealed that curcumin reduce levels of ALT and AST, and reversed TLR4/NF-κB signaling pathway caused by hepatic I/R stimulation in liver tissues. These results suggested that curcumin ameliorates hepatic I/R injury, which may be mediated in part via the TLR4/NF-κB signaling pathway.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 18676

Publication Alerts

Post-Publication Promotion

Publication Discount

Research Papers:

Curcumin protects against hepatic ischemia/reperfusion induced injury through inhibiting TLR4/NF-κB pathway

Abstract